Researchers observed responses in patients with synovial sarcoma or myxoid/round cell liposarcoma treated with lete-cel.
Initial Keytruda showed consistent antitumor activity and safety in patients with advanced bladder cancer ineligible for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback